Prestige International Inc. PGINF
Rating
Rating Factors
Company Overview
Prestige International Inc. is a Japan-based pharmaceutical and healthcare company focused primarily on over-the-counter (OTC) medicines and select prescription pharmaceuticals. The company operates within the consumer healthcare and pharmaceutical industries, with a business model centered on identifying unmet medical needs, developing differentiated products, and marketing them through strong branding and physician engagement. Its core revenue drivers are OTC drugs addressing dermatology, ophthalmology, gastrointestinal, and women’s health indications, complemented by a smaller prescription drug portfolio.
Founded in 1957, Prestige International evolved from a domestic pharmaceutical distributor into a product-oriented healthcare company with in-house planning, regulatory, and marketing capabilities. A defining strategic characteristic is its “unique niche” approach—targeting therapeutic areas that are underserved by major pharmaceutical firms but have stable consumer demand. This positioning allows the company to maintain brand strength and pricing power in specific healthcare categories within Japan and selected international markets.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $4.16
- Current
- $4.08
- High
- $4.16
Valuation
Dividends and Shares
Corporate Info
Chiyoda-ku
Tokyo, 102-0083